ARTICLE | Company News
Management tracks: Vectura, Editas, Assembly, Camp4, Tempus, Passage Bio, Boundless Bio and Prometheus
October 30, 2019 12:16 AM UTC
Updated on Oct 30, 2019 at 1:00 AM UTC
Inhaled drug delivery platform company Vectura Group plc (LSE:VEC) hired Will Downie as CEO and executive director, effective Nov. 7. CFO Paul Fry has been serving as interim CEO since James Ward-Lilley stepped down in June. Downie was SVP, global sales and marketing at Catalent Inc. (NYSE:CTLT).
Judith Abrams has joined Editas Medicine Inc. (NASDAQ:EDIT) as the gene editing company’s CMO. She was the franchise lead, immunology and neurology, global drug safety innovation at the EMD Serono Inc. division of Merck KGaA (Xetra:MRK)...